Results
|
340921.
|
|
|
340922.
|
|
|
340923.
|
|
|
340924.
|
|
|
340925.
|
|
|
340926.
|
|
|
340927.
|
|
|
340928.
|
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) [electronic resource] by
- Poynard, T
- Marcellin, P
- Lee, S S
- Niederau, C
- Minuk, G S
- Ideo, G
- Bain, V
- Heathcote, J
- Zeuzem, S
- Trepo, C
- Albrecht, J
Producer: 19981120
In:
Lancet (London, England) vol. 352
Availability: No items available.
|
|
340929.
|
|
|
340930.
|
|
|
340931.
|
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. [electronic resource] by
- Wang, Shixia
- Pal, Ranajit
- Mascola, John R
- Chou, Te-Hui W
- Mboudjeka, Innocent
- Shen, Siyuan
- Liu, Qin
- Whitney, Stephen
- Keen, Timothy
- Nair, B C
- Kalyanaraman, V S
- Markham, Philip
- Lu, Shan
Producer: 20060802
In:
Virology vol. 350
Availability: No items available.
|
|
340932.
|
|
|
340933.
|
|
|
340934.
|
|
|
340935.
|
|
|
340936.
|
|
|
340937.
|
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual. [electronic resource] by
- Gilchrist, Gail
- Swan, Davina
- Shaw, April
- Keding, Ada
- Towers, Sarah
- Craine, Noel
- Munro, Alison
- Hughes, Elizabeth
- Parrott, Steve
- Strang, John
- Taylor, Avril
- Watson, Judith
Producer: 20171122
In:
Harm reduction journal vol. 14
Availability: No items available.
|
|
340938.
|
|
|
340939.
|
|
|
340940.
|
Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection. [electronic resource] by
- Srivastava, Ruchi
- Khan, Arif A
- Garg, Sumit
- Syed, Sabrina A
- Furness, Julie N
- Vahed, Hawa
- Pham, Tiffany
- Yu, Howard T
- Nesburn, Anthony B
- BenMohamed, Lbachir
Producer: 20170515
In:
Journal of virology vol. 91
Availability: No items available.
|